A beta-cell specific global approach for drug identification in Type 2 Diabetes

Type 2 Diabetes is a major health burden world-wide and current treatments cannot stop or slow the progression of this serious disease. This project created a novel drug development approach to identify drugs that can slow, stop or even prevent diabetes.